Re: Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases: A Randomized Clinical Trial

Samir S. Taneja

doi:10.1016/j.juro.2017.06.009

Re: Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases: A Randomized Clinical Trial

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	The Journal of urology
Volume	198
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2017.06.009
State	Published - Sep 1 2017

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2017.06.009

Cite this

@article{9e17b2f00eaa42069b4e609b069043c8,

title = "Re: Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases: A Randomized Clinical Trial",

author = "Taneja, {Samir S.}",

year = "2017",

month = sep,

day = "1",

doi = "10.1016/j.juro.2017.06.009",

language = "English (US)",

volume = "198",

journal = "The Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Re

T2 - Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases: A Randomized Clinical Trial

AU - Taneja, Samir S.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85062869440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062869440&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2017.06.009

DO - 10.1016/j.juro.2017.06.009

M3 - Comment/debate

C2 - 28817913

AN - SCOPUS:85062869440

SN - 0022-5347

VL - 198

JO - The Journal of urology

JF - The Journal of urology

IS - 3

ER -

Re: Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases: A Randomized Clinical Trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this